The present disclosure lies in the field of medical radiotherapy and relates to an applicator for a medical radiotherapy device, an applicator system for a medical radiotherapy device and a method for using an applicator or an applicator system. The applicator includes an applicator head and an applicator body. The applicator head and the applicator body are embodied such that the applicator head can be assembled on, and disassembled from, the applicator body, in each case without damage.

Provided is a process of producing activated particles comprising .sup.188Re-isotopes and/or .sup.186Re-isotopes by irradiating non-volatile and water-insoluble starting particles comprising a rhenium compound with neutrons. Further provided is a process of producing corresponding non-volatile and water-insoluble starting particles. Further provided are respective starting particles and activated particles, respectively, and a composition comprising a plurality of activated particles. The activated particles, and the composition comprising same are suitable for use in radionuclide therapy, and for cosmetic applications.

The present disclosure falls into the field of medical apparatus, and discloses a radiation therapy apparatus and a beam imaging method, wherein the radiation therapy apparatus includes: a treatment head including multiple radiation sources distributed on one side of a target region, radiation beams emitted by the multiple radiation sources intersecting in the target region, and a lesion being located within the target region; a beam detector used for receiving a radiation beams passing through the lesion and emitted by the radiation sources to acquire projection data of each radiation beam passing through the lesion, and generating a slice image of the lesion according to the acquired projection data; and a processor used for constructing an image of the lesion in the target region based on the slice image generated by the beam detector. The radiation therapy apparatus of the present disclosure can implement a three-dimensional imaging process in real time, the treatment head of the beam therapy apparatus can be directly used for tracking tumors, and the human body can be positioned according to the reconstructed three-dimensional image before surgery.

A radioactive source removing and introducing tooling includes a first support frame, a shield door disposed on the first support frame, a shield cover located on the shield door, and a first pull rod device. The shield door includes a movable first shield block. The shield cover is able to be separated from the shield door, and the shield cover includes one opening and one accommodation space. The first pull rod device includes a pull rod and a first connection portion disposed on the pull rod, and the pull rod is able to extend into the shield cover and drive the first connection portion to move inside the accommodation space of the shield cover.

In one aspect, a connector assembly includes a delivery conduit defining a conduit lumen and a securable connector configured to secure the delivery conduit to a medical device hub defining a medical device hub lumen. The conduit lumen includes a constant diameter region along a portion of the delivery conduit and a transition region extending from the delivery conduit to the distal end. A transition region diameter of the transition region gradually increases from the constant diameter region to a distal end of the delivery conduit. The securable connector is coupled to an outer surface of the delivery conduit and is slidable along a portion thereof. The securable connector is configured to receive the medical device hub. The securable connector is secured relative to the delivery conduit so as to fluidically couple the conduit lumen with the medical device hub lumen.

A radiotherapy device and a control driving method thereof are provided. The radiotherapy device includes a radiation source apparatus, the radiation source apparatus includes a plurality of radiation sources and a collimator, and source points of the plurality of radiation sources are within a preset included angle range in a longitude direction. The preset included angle range is 5 to 60 degrees. The collimator is provided with a plurality of collimating hole groups, and an included angle of each of the collimating hole groups in the longitude direction is within the preset included angle range; and each of the collimating hole groups includes a plurality of collimating holes, and radiation beams emitted from the plurality of radiation sources intersect at a common focus after passing through the collimating holes of the collimating hole groups.

Multiphase microspheres for radioembolization include two-phase microspheres and three-phase microspheres prepared by a microfluidic process. The multiphase microspheres include a primary phase and a first secondary phase surrounded by the primary phase. The primary phase includes a first resin. The first secondary phase includes a second resin and at least one of a radioactive isotope or a compound including at least one radioactive element. Three-phase microspheres additionally include a second secondary phase discrete from the first secondary phase and also surrounded by the primary phase. The second secondary phase may be a gas such as air. The microspheres may be formed by a microfluidic process.

The disclosure pertains to improvements in a gamma radiation source, typically containing low-density alloys or compounds or composites of iridium in mechanically deformable and compressible configurations, within a sealed encapsulation, and methods of manufacture thereof.

Provided herein are methods of isolating and using radioactive mercury. In particular, provided herein are methods of isolating radioactive mercury including the use of a thiacrown ether, and using the isolated radioactive mercury in therapeutic and/or imaging applications.

Methods and systems for selection of dosimetry levels and sphere amounts of radioactive compounds for use in a radioembolization procedure for procedure planning may include inputting activity parameter information into a dosimetry portal of a dosimetry selection tool; determining a customized activity based on the activity parameter information and one or more customized activity algorithms; generating one or more sphere amount and dosage recommendations based on the customized activity and one or more dosimetry selection algorithms; selecting one of the one or more sphere amount and dosage recommendations as a selected sphere amount and dosage recommendation; and generating a radioactive compound order for the radioembolization procedure based on the customized activity and the selected sphere amount and dosage recommendation.